Unfortunately, this can happen even if you havent yet hit your goal weight or a weight that is optimal for your health
Here's how they compare so you and your clinician can choose the right fit
TripleHormone-Receptor Agonist Retatrutide for Obesity a Phase 2 Trial
After you've paid, you will need to complete the intake process by answering a quick medical questionnaire about your health and weight loss goals, providing a BEFORE photo and verify your identity by uploading a photo ID
The single most important distinction: Multi-molecule combination (two peptides, one vial): CagriSema = cagrilintide (amylin analog) + semaglutide (GLP-1 agonist) Multi-target single molecule (one peptide, multiple receptors): Tirzepatide = one molecule activating GLP-1 + GIP receptors (dual agonist) Retatrutide = one molecule activating GLP-1 + GIP + glucagon receptors (triple agonist) So CagriSema is a blend
Per FTC guidelines (16 CFR Part 465, effective October 21, 2024), consumers are also encouraged to evaluate whether reviews reflect verified purchases
